| Session | Time | Topic | Faculty Name |
|---|---|---|---|
| 08:00 – 09:15 | Quiz Prelims : All Teams | Quiz Masters: Dr. Karthik Bommannan, Dr. V A Arun | |
| Session 1: | Integrating Myeloma Investigations into Clinical Practices | Chairpersons: Dr. Mayur Parihar & Dr. Kunal Sehgal | |
| 09:15 – 09:20 | Welcome | Dr. Deepak Mishra | |
| 09:20 – 09:35 | Making a Diagnosis of Multiple Myeloma | Dr. Prashant Kapoor | |
| 09:40 – 09:55 | Serum Electrophoresis | Dr. Ritu Aggarwal | |
| 10:00 – 10:15 | Approaches to Assessment of Minimal Residual Disease | Dr. Sreejesh Saeedharanunni | |
| 10:20 – 10:35 | Bone Imaging: Beyond Skeletal Surveys | Dr. Chandramouli Nagarajan | |
| 10:40 – 10:55 | Quality control and challenges in Myeloma MRD | Dr. Prashant Tembhare | |
| 10:30 - 11:20 | Running Tea / Coffee | ||
| Session 2: | Multiple Myeloma : Initial Diagnosis and Treatment | Chairpersons: Dr. Subhash Varma & Dr. Sanjeevan Sharma | |
| 11:20 – 11:35 | The Core Pillars of Myeloma Induction Therapy | Dr. Shaji Kumar | |
| 11:40 – 11:55 | Best Consolidation/Maintenance Strategies Post ASCT | Dr. Sundar Jagannath | |
| 12:00 – 12:20 | Managing NDMM in Resource-Constrained Settings | Dr. Lalit Kumar | |
| 12:20 – 13:00 | Q & A Session on Diagnosis and Treatment of NDMM | Moderator: Lt Gen (Dr) Velu Nair Panelists: Dr. B K Smruti, Dr. Saurabh Bhave, Dr. Ketan Modak, Dr. Biswajit Dubashi, Dr. Manish K Singh, Dr. Sreejesh Sreedharanunni, Dr. Sanjeev Yadav |
|
| Break | 13:00 – 14:00 | Lunch- with E-Poster presentation | Co-Ordinator: Dr. Bhausaheb Bagal
Discussants: Dr. Gaurav Prakash, Dr. Atul Sharma, Dr. Anupama Borker, Dr. Sanket Shah, Dr. Asish Rath & Dr. Priyanka Samal |
| Session 3: | Transplant Ineligible/ Relapsed Refractory Multiple Myeloma | Chairpersons: Dr. Santanu Basu & Dr. Suman Pramanik | |
| 14:00 – 14:15 | Induction Treatment of Transplant Ineligible/Elderly NDMM | Dr. Tapan Saikia | |
| 14:20 – 14:35 | Approaches to Treatment of RRMM Excluding T-Cell Directed Therapy | Dr. Chandramouli Nagarajan | |
| 14:40 – 14:55 | Treatment of Relapse Post-Transplant/Role of Allo-HSCT in MM | Dr. Anupam Chakrapani | |
| 15:00 – 15:15 | New Drugs on the Horizon: Ongoing Clinical Trials for RRMM | Dr. Sundar Jagannath | |
| 15:20 – 16:00 | Challenges in Managing Relapse Refractory MM in India | Moderator: Dr. Biju George Panelists: Dr. Shilpa Gupta, Dr. Soumya Mukherjee, Dr. Chirag Shah, Dr. Subhaprakash Sanyal, Dr. Basab Bagchi, Dr. Sanju Cyriac |
|
| 16:00 – 16:30 | Tea / Coffee | ||
| Session 4: | Supportive Management in Myeloma | Chairpersons: Dr. Maitreyee Bhattacharyya & Dr. Govind Babu | |
| 16:30 – 16:45 | Management of Renal Complications in MM | Dr. Manu Dogra | |
| 16:50 – 17:05 | Recommendations for Treatment of Myeloma Related Bone Disease: Drugs and Dosing | Dr. Noopur Raje | |
| 17:10 – 17:25 | Decreasing Infectious Complications in MM: Prophylaxis and Vaccination | Dr. Priya Sampathkumar | |
| 17:30 – 17:45 | Is There a Role of Radiotherapy in the Current Management of MM? | Dr. Rimpa Achari | |
| 17:45 – 18:20 | Adequate Pain Management and Quality of Life Issues in NDMM | Moderator: Dr. Joseph John Panelists: Dr. Arvind Mathur, Dr. Gaurav Prakash, Dr. Atul Sharma, Dr. Naved Tamboli, Dr. Smitha Saldanha |
Session 5: | Indian Data | Chairpersons: Dr. Reetu Jain & Dr. Prantar Chakrabarti |
| 18:30 – 18:45 | Artificial Intelligence in Myeloma | Dr. Ritu Gupta | |
| 18:50 – 19:05 | Screening of monoclonal gammopathies | Col. (Dr.) Uday Yanamandra | |
| 19:10 – 19:25 | MALDI-TOF Mass Spectrometry for M Protein Analysis: from Bench to Bedside | Dr. Nikita Mehra | |
| 19:30 – 19:45 | Phase 1/2 Study of Ribrecabtagene Autoleucel, a BCMA–Directed CAR-T Cell Therapy, in Relapsed-Refractory Multiple Myeloma (SWASTH trial) | Dr. Hari Menon | |
| 19:45 – 20:00 | NGS in Multiple Myeloma | Dr. Nikhil Patkar | |
| End of Day 1 : Dinner | |||
| Session | Time | Topic | Faculty Name |
|---|---|---|---|
| 08:00 - 10:20 | Conversation with Myeloma Experts | Case Presentors: Making sense of the Evolving treatment landscapes | |
| Session 1 | 08:00 - 08:50 | ||
| Conference Room | Seminar Room 1 | Seminar Room 2 | |
| Management of complicated NDMM | PCD: Amyloidosis & LPL | Infection and vaccination | |
| Dr. Shaji K Kumar Dr. Nikhil Munshi Dr. Lalit Kumar |
Dr. Sundar Jagannath Dr. Prashant Kapoor Dr. Biju George Dr. Ashutosh Wechalekar |
Dr. Priya SampathKumar Dr. Noopur Raje Dr. Subhash Verma |
|
| Case 1: Dr. Chirag Shah Case 2: Dr. Ashish Dixit Case 3: Dr. Vaibhav Gupta |
Case 1: Dr. Prantar Chakrabarti Case 2: Dr. Ganesh Jaishetwar Case 3: Dr. Baalamurugan |
Case 1: Dr. Rajat Pincha Case 2: Dr. Avinash Singh Case 3: Dr. Aradhana Sahoo |
|
| Break | 08:50 - 09:20 | Breakfast | |
| Session 2 | 09:20 - 10:20 | ||
| Related PCD | Relapsed Refractory Myeloma | Planning prospective trials in Myeloma / PCD | |
| Dr. Chandramaouli Dr. Sundar Jagannath Dr. Hemant Malhotra |
Dr. Shaji K Kumar Dr. Nikhil Munshi Dr. Joseph John |
Dr. Vincent Rajkumar Dr. Ashutosh Wechalekar Dr. Govind Babu |
|
| Case 1: Dr. Sumeet Mirgha Case 2: Dr. Sanket Shah Case 3: Dr. Raghuram Mahishi |
Case 1: Dr. Priyanka Samal
Case 2: Dr. Vishvdeep khushoo Case 3: Dr. Arijit Nag |
Trial 1: Dr. Bhausaheb Bagal
Trial 2: Dr. Aditya Jandial Trial 3: Dr. Dibakar Podder |
|
| 10:00 - 11:00 | Running Tea / Coffee | ||
| Session 1: | Precursor Conditions: Overview and Therapeutic Intervention | Chairpersons: Dr. Hemant Malhotra & Dr. Ankita Sen | |
| 10:30 - 10:45 | Identifying Patients with Myeloma Precursor Conditions: Lessons from iSTOPMM and PROMISE Study | Dr. Shaji Kumar | |
| 10:50 - 11:05 | Immune Progression from MGUS to SMM | Dr. Nikhil Munshi | |
| 11:10 - 11:25 | Can Intervention Prevent Progression in MM: Ongoing Clinical Trials for SMM | Dr. Vincent Rajkumar | |
| 11:30 - 11:45 | Risk stratification of Multiple Myeloma | Dr. Sameer Melinkeri | |
| 11:50 - 12:30 | Round Table Discussion on Precursor Disease Management in India | Moderator: Dr. Hari Menon Panelists: Dr. Ajay Gogia, Dr. Ashish Dixit, Dr. Tuphan Kanti Dolai, Dr. Krishna Kumar Rathnam, Dr. Shouriyo Ghosh |
|
| Parallel session | Mini-Oral Paper Presentation |
Co-ordinator: Dr. Hari Menon
Discussants: Dr. Navin Khattry, Dr. Ritu Jain, Dr. Vishvdeep Khushoo, Dr. Gurleen Oberoi & Dr. Sushant Vinarkar |
|
| Parallel session | 10:30 - 13:00 | “Myeloma Awareness and Education: Q & A with National and International Experts” Session Co-ordinator: Dr. Debranjani Chattopadhyay |
Moderator: Dr. Saurabh Bhave National Faculty: Dr. Mammen Chandy, Dr. Prantar Chakrabarti, Ms. Tiash Sinha, Mr. Sayantan Chattopadhyay, Dr. Gayatri Bhat, Mrs. Vinita Menon International Faculty: Dr. Noopur Raje Venue : Premasharaya, DC Block, Action area-1, Newtown, Rajarhat, [opp: Techno India College] West Bengal, Kolkata 700160 |
| Break | 12:30 - 13:15 | Lunch | |
| ----- | Chairpersons: Lt. Gen. (Dr.) Velu Nair (Retd), Dr. Mammen Chandy & Dr. Tapan Saikia | ||
| 13:15 - 13:45 | Title: Keynote: A Journey in MM & Academic Medicine | Dr. Nikhil Munshi | |
| 13:45 - 15:00 | INAUGURATION and IMF activities | Dr. Pankaj Malhotra / Col. (Dr.) Uday Yanamandra | |
| 15:00 - 15:15 | IMF Activities in Asia and AMN Clinical Trials | Dr. Vincent Rajkumar | |
| 15:15 - 15:30 | The way forward in SAARC Nations… | Dr. Pankaj Malhotra | |
| 15:30 - 15:45 | IMAGe Consensus Guidelines | Col. (Dr.) Uday Yanamandra | |
| 15:45-16:15 | Tea / Coffee | ||
| Session 2: | Plasma Cell Dyscrasia-Related Disorders | Chairpersons: Dr. Utpal Chaudhuri & Dr. Gurleen Oberoi | |
| 16:15 – 16:35 | Making Pathological Classification of MGRS Easy | Dr. Rajan Duggal | |
| 16:35 – 16:55 | Management of MGRS and Transplant in Myeloma with Renal Dysfunction | Dr. Mammen Chandy | |
| 16:55 – 17:15 | Current management of Waldenstrom Macroglobulinemia | Dr. Prashant Kapoor | |
| 17:15 – 17:35 | Myriad of manifestations in MGCS including POEMs | Dr. Sundar Jagannath | |
| 17:35 – 18:15 | Panel discussion on Dysproteinemias | Moderator: Dr. Neeraj Siddarthan Panelists: Dr. Anupama Borker, Dr. Aditya Jandial, Dr. Rajat Pincha, Dr. Khaliqur Rahman, Dr. Sushant Vinarkar |
|
| Session 3: | 18:15 - 19:45 | Best Oral Paper session | Chairpersons: Dr. Sadashivudu Gundeti & Lt. Gen. (Dr.) Velu Nair
Session Co-ordinator: Dr. V. A. Arun Discussants: Dr. Nikhil Munshi, Dr. Sundar Jagannath, Dr. Mamman Chandy, Dr. Subash Varma, & Dr. Navin Khattry |
| 1. | Characterizing The Dna Methylation Landscape In Monoclonal Gammopathy Of Undetermined Significance And Multiple Myeloma | ||
| 2. | Prognostic Relevance Of Peripheral Blood Measurable Residual Disease Assessment In Newly Diagnosed Multiple Myeloma | ||
| 3. | Circulating Clonal Plasma Cells And Its Association With Prognostic Markers In Multiple Myeloma | ||
| 4. | Exploring The Associations Of Tp53 Gene Aberrations Amongst Routine Diagnostic Investigations In Multiple Myeloma Patients | ||
| 5. | Real-world Analysis Of Prolonged Lenalidomid Induction Therapy And Its Impact On Stem Cell Mobilisation For Autologous Transplantation In Multiple Myeloma | ||
| 6. | Outcomes Of Autologous Stem-cell Transplant As Per Melphalan Dose In Patients With Multiple Myeloma - A 15-year Retrospective Institutional Analysis | ||
| 18:45 - 19:30 | Pfizer Sponsored Session | Conference room | |
| 19:00 - 19:30 | Seminar Room 1 "Medical Ethics" | Dr. Saswata Saha & Dr. Reena Nair | |
| End of Day 2 : Dinner | |||
| Session | Time | Topic | Faculty Name |
|---|---|---|---|
| 07.30 - 09.00 | Quiz: Qualifying Teams | Quiz Masters: Dr. Jasmita Dass, Dr. Sumeet Mirgh | |
| Session 1: | Clinico-Pathological Case Discussion | ||
| 09.00 - 10.00 | Case presentation: Dr. Ritambhra Nada | Discussant : Brig (Dr) Ranjith Nair | |
| Session 2: | Difficult to Diagnose and Treat Plasma Cell Dyscrasias | Chairpersons: Dr. Sandeep Shah & Dr. Damodar Das | |
| 10.00 - 10.20 | Diagnosis, Risk stratification & Management of AL Amyloidosis | Dr. Ashutosh Wechalekar | |
| 10.25 - 10.40 | Management of extramedullary disease & Plasma Cell Leukemia | Dr. Gaurav Prakash | |
| Session 3: | Immune Therapies | Chairpersons: Dr. Tapan Saikia & Dr. Shilpa Bhartia | |
| 10.45 - 11.00 | Updates on Bispecific Antibodies in Multiple Myeloma | Dr. Sharat Damodar | |
| 11.05 - 11.20 | Sequencing of CAR T cell therapies in management of RRMM | Dr. Noopur Raje | |
| 11.20 - 12.00 | Managing Toxicities of CAR’s and Bispecifics Across India: Making Expertise Available | Moderator: Dr. Navin Khattry Panelists: Dr. Rajib De, Dr. Vishvdeep Khushoo, Dr. Avinash Singh, Dr. Bhausaheb Bagal, Dr. Dibakar Podder, Dr. Sugeeth Mangalapilly Thambi |
|
| Session 4: | Precision therapy: Directions and Challenges | Chairpersons: Dr. Rajat Bajaj, Dr. Mipsang Lama & Dr. Siddhartha Sankar roy | |
| 12.00 - 12.15 | Precision therapy in Myeloma and the possibility of Cure | Dr. Vincent Rajkumar | |
| 12.20 - 12.35 | Physician’s take-away from the IMC 2025 | Dr. Tapan Saikia | |
| 12.40 - 13.00 | Valedictory and Vote of Thanks | Dr. Mayur Parihar & Dr. Jeevan Kumar | |
| End of Day 3 : LUNCH | |||